Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes
Dupuy-McCauley K, Schwartz AR, Javaheri S, Germany R, McKane S, Morgenthaler TI. Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes. <i>J Clin Sleep Med</i>. 2025;21(12):2113-2120.
Authors
- Timothy I. Morgenthaler (ORCID: https://orcid.org/0000-0002-2614-3793)
- Scott McKane (ORCID: https://orcid.org/0000-0002-2886-6864)
- Kara Dupuy-McCauley (ORCID: https://orcid.org/0000-0003-1874-7818)
- Shahrokh Javaheri
- Robin Germany (ORCID: https://orcid.org/0000-0001-5182-4745)
- Alan R. Schwartz (ORCID: https://orcid.org/0000-0001-9222-3751)
Institutions
- Mayo Clinic (US)
- University of Maryland Medical System (US)
- Universidad Peruana Cayetano Heredia (PE)
- Vanderbilt University (US)
- Minnesota Zoo (US)
- Bethesda North Hospital (US)
- Cargill (United States) (US)
- Towson University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Clinical Sleep Medicine
- Published
- 2025-09-30
- DOI
- https://doi.org/10.5664/jcsm.11904
- Citations
- 1
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.81